2 completed, 2 unknown, 2 withdrawn, 1 recruiting. 3 Phase 2, 3 Phase 4, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 4 | 3 | Completed 2, Unknown 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Anna Cruceta: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Simvastatin in Alcoholic Liver Fibrosis Simvastatin 40mg - Liver Fibrosis, Alcohol Abuse | Phase 2 / Phase 3 | Recruiting | Anna Cruceta | 90 | 2022-02-22 | 2024-12-04 |
| Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection 50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide - HIV Primary Infection | Phase 2 | Unknown | Anna Cruceta | 66 | 2020-12-04 | 2021-07-19 |
| Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer Lymphoseek, Nanocoll - Head Cancer, Neck Cancer | Phase 4 | Unknown | Anna Cruceta | 30 | 2020-03-01 | 2020-02-20 |
| Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure Albumin, Midodrine, Octreotide - Fibrosis, Renal Failure | Phase 2 | Withdrawn | Anna Cruceta | 2016-07-01 | 2019-02-15 | |
| Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes. Vitamine C, Liraglutide 6 mg - Type 1 Diabetes Mellitus | Phase 1 | Withdrawn | Anna Cruceta | 2014-05-01 | 2019-02-15 | |
| Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine ATRIPLA - HIV | Phase 4 | Completed | Anna Cruceta | 61 | 2013-06-03 | 2025-07-18 |
| HIV Patients With Chronic Hepatitis C Genotype 1 Infection Who Failed Previously to Peginterferon /Ribavirin boceprevir, Ribavirin, Peginterferon alfa-2a - Hepatitis C, HIV Infections | Phase 3 | Terminated | Anna Cruceta | 108 | 2013-03-10 | 2025-08-24 |
| Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users Liraglutide, Sitagliptin - DIABETES Mellitus Type 2 Not Well Controlled | Phase 4 | Completed | Anna Cruceta | 13 | 2013-03-01 | 2015-09-15 |
Acquired Immunodeficiency Syndrome (1) · Alcoholism (1) · Breast Neoplasms (1) · Coinfection (1) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Fibrosis (1) · HIV Infections (1) · Head and Neck Neoplasms (1) · Hepatitis C (1) · Hepatorenal Syndrome (1) · Liver Cirrhosis (1) · Melanoma (1) · Renal Insufficiency (1)
Liraglutide (2) · Albumins (1) · Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1) · Emtricitabine (1) · Midodrine (1) · N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide (1) · Octreotide (1) · Ribavirin (1) · Simvastatin (1) · Sitagliptin Phosphate (1) · Tenofovir (1) · bictegravir (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1) · efavirenz (1) · peginterferon alfa-2a (1)
Spain (8)
Antonio Ceriello A Ceriello, MD (1) · Antonio Ceriello, MD (1) · Esteban Martinez, MD (1) · Josep Mallolas, MD (1) · Pere Gines, Md (1)
PMID 29746294, PMID 30946150, PMID 40824526, PMID 41676981
2019 (1)